These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30356024)

  • 21. Emerging roles of HSF1 in cancer: Cellular and molecular episodes.
    Wang G; Cao P; Fan Y; Tan K
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188390. PubMed ID: 32653364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018.
    Liu W; Li Q; Hu J; Wang H; Xu F; Bian Q
    Bioorg Med Chem; 2019 Dec; 27(23):115150. PubMed ID: 31635893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics.
    Kumar S; Tomar MS; Acharya A
    Future Oncol; 2013 Oct; 9(10):1573-86. PubMed ID: 24106905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
    Maslah H; Skarbek C; Pethe S; Labruère R
    Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.
    Cui J; Li S
    Curr Med Chem; 2014; 21(5):519-52. PubMed ID: 24083611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat shock protein 90: a unique chemotherapeutic target.
    Cullinan SB; Whitesell L
    Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted biopharmaceuticals for cancer treatment.
    Zhou L; Xu N; Sun Y; Liu XM
    Cancer Lett; 2014 Oct; 352(2):145-51. PubMed ID: 25016064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs.
    Wang X; Xu L; Lao Y; Zhang H; Xu H
    Curr Protein Pept Sci; 2018 Feb; 19(4):380-388. PubMed ID: 28059040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1.
    Dong B; Jaeger AM; Hughes PF; Loiselle DR; Hauck JS; Fu Y; Haystead TA; Huang J; Thiele DJ
    Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cells.
    Purwana I; Liu JJ; Portha B; Buteau J
    Diabetologia; 2017 Aug; 60(8):1432-1441. PubMed ID: 28547133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock proteins in cancer: targeting the 'chaperones'.
    Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z
    Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent studies on natural products as anticancer agents.
    Ravelo AG; Estévez-Braun A; Chávez-Orellana H; Pérez-Sacau E; Mesa-Siverio D
    Curr Top Med Chem; 2004; 4(2):241-65. PubMed ID: 14754457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rethinking HSF1 in Stress, Development, and Organismal Health.
    Li J; Labbadia J; Morimoto RI
    Trends Cell Biol; 2017 Dec; 27(12):895-905. PubMed ID: 28890254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodrug strategy for cancer cell-specific targeting: A recent overview.
    Zhang X; Li X; You Q; Zhang X
    Eur J Med Chem; 2017 Oct; 139():542-563. PubMed ID: 28837920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of HSF1 protein stabilization: An updated review.
    Huang C; Wu J; Xu L; Wang J; Chen Z; Yang R
    Eur J Pharmacol; 2018 Mar; 822():69-77. PubMed ID: 29341886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
    McConnell JR; Buckton LK; McAlpine SR
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3409-14. PubMed ID: 26164188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
    Basmadjian C; Thuaud F; Ribeiro N; Désaubry L
    Future Med Chem; 2013 Dec; 5(18):2185-97. PubMed ID: 24261894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
    Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
    Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.